v3.26.1
SEGMENT AND ENTERPRISE-WIDE INFORMATION - Segment Reporting Information by Segment (Details)
$ in Thousands
 12 Months Ended
Mar. 28, 2026
USD ($)
unit
Mar. 29, 2025
USD ($)
Mar. 30, 2024
USD ($)
Segment Reporting [Line Items]      
Number of reportable segments | unit 3    
Net revenues $ 1,334,027 $ 1,360,824 $ 1,309,055
Significant segment expenses and operating performance:      
Cost of goods sold 546,441 611,866 617,507
Selling, general and administrative 442,421 436,789 429,780
Research and development 59,766 62,722 54,435
Operating income 156,734 221,817 164,883
Amortization of acquired intangible assets 43,998 48,261 32,031
Impairment of intangible assets 86,546 2,391 10,419
Interest and other expense, net (28,704) (9,746) (13,018)
Income before provision for income taxes 128,030 212,071 151,865
Total net revenues 1,334,027 1,360,824 1,309,055
Depreciation and amortization 111,717 115,586 97,215
Total long-lived assets 305,761 284,052  
Blood Center      
Significant segment expenses and operating performance:      
Total net revenues 221,267 261,124 283,231
Hospital      
Significant segment expenses and operating performance:      
Total net revenues 588,304 564,269 456,289
Plasma      
Segment Reporting [Line Items]      
Net revenues 524,456 535,431 569,535
Significant segment expenses and operating performance:      
Depreciation and amortization 47,368 48,264 45,712
Total long-lived assets 206,365 189,833  
Plasma | Plasma      
Significant segment expenses and operating performance:      
Total net revenues 524,456 535,431 569,535
Blood Center      
Segment Reporting [Line Items]      
Net revenues 221,267 261,124 283,231
Significant segment expenses and operating performance:      
Depreciation and amortization 7,160 10,077 13,391
Total long-lived assets 39,677 40,337  
Hospital      
Segment Reporting [Line Items]      
Net revenues 588,304 564,269 456,289
Significant segment expenses and operating performance:      
Depreciation and amortization 57,189 57,245 38,112
Total long-lived assets 59,719 53,882  
Apheresis | Blood Center      
Significant segment expenses and operating performance:      
Total net revenues 220,861 213,134 211,173
Whole Blood | Blood Center      
Significant segment expenses and operating performance:      
Total net revenues 406 47,990 72,058
Interventional Technologies | Hospital      
Significant segment expenses and operating performance:      
Total net revenues 234,007 255,019 174,285
Blood Management Technologies | Hospital      
Significant segment expenses and operating performance:      
Total net revenues 354,297 309,250 282,004
Operating Segments [Member] | Plasma      
Significant segment expenses and operating performance:      
Cost of goods sold 214,135 237,050 264,042
Selling, general and administrative 105,323 98,418 109,729
Research and development 20,203 15,453 13,797
Operating income 184,795 184,510 181,967
Operating Segments [Member] | Blood Center      
Significant segment expenses and operating performance:      
Cost of goods sold 112,666 142,512 165,564
Selling, general and administrative 54,133 60,023 67,339
Research and development 4,492 5,770 7,956
Operating income 49,976 52,819 42,372
Operating Segments [Member] | Hospital      
Significant segment expenses and operating performance:      
Cost of goods sold 203,227 199,499 167,172
Selling, general and administrative 247,251 241,760 209,680
Research and development 34,091 34,035 27,239
Operating income 103,735 88,975 52,198
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]      
Significant segment expenses and operating performance:      
Operating income 156,734 221,817 164,883
Amortization of acquired intangible assets 49,812 63,217 35,378
Acquisition, integration and divestiture related costs (14,155) (22,904) (11,249)
Restructuring and restructuring related costs 3,218 21,158 23,588
Digital transformation costs 21,526 20,273 15,667
Remeasurement of contingent consideration 1,879 23,022 0
Impairment of intangible assets (86,546) (2,391) (10,419)
Other $ (8,394) $ 2,434 $ (15,353)